Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.45 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | P4HB | P07237 | 1/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12181997 | 0.95 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL12802176 | 0.95 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL29511660 | 0.95 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL17401217 | 0.95 | LPL (0.49) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL19164658 | 0.94 | LPL (0.47) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL17816719 | 0.94 | LPL (0.47) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL19164440 | 0.94 | LPL (0.47) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL20225283 | 0.92 | LPL (0.41) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL20225286 | 0.92 | LPL (0.41) | LPLLIPGPRMT5WDR77P4HB | |
| SCHEMBL23349135 | 0.91 | LPL (0.45) | LPLLIPGPRMT5WDR77P4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147336-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | DOOSAN SOLUS CO., LTD. (KR) | 2021-05-20 | — | — | US | disclosed |
| US-20210147336-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | DOOSAN SOLUS CO., LTD. (KR) | 2021-05-20 | — | — | US | disclosed |
| US-20210143327-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | DOOSAN SOLUS CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| WO-2021075852-A1 | COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2021-04-22 | — | — | WO | disclosed |
| WO-2020111663-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 두산솔루스 주식회사 | 2020-06-04 | — | — | WO | disclosed |
| WO-2020111663-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 두산솔루스 주식회사 | 2020-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147336-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | OR10J3, ORAI2, OR51E2 | LPL 771/4885LIPG 1234/4885PRMT5 3012/4885 |
| US-20210143327-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | OR10J3, ICOSLG, L1CAM | LPL 147/4885LIPG 370/4885PRMT5 3154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.